JP2024123233A5 - - Google Patents

Download PDF

Info

Publication number
JP2024123233A5
JP2024123233A5 JP2024103130A JP2024103130A JP2024123233A5 JP 2024123233 A5 JP2024123233 A5 JP 2024123233A5 JP 2024103130 A JP2024103130 A JP 2024103130A JP 2024103130 A JP2024103130 A JP 2024103130A JP 2024123233 A5 JP2024123233 A5 JP 2024123233A5
Authority
JP
Japan
Prior art keywords
marker
methylation
max
nucleic acid
methylation marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024103130A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024123233A (ja
Filing date
Publication date
Priority claimed from PCT/US2019/063401 external-priority patent/WO2020112869A1/en
Application filed filed Critical
Publication of JP2024123233A publication Critical patent/JP2024123233A/ja
Publication of JP2024123233A5 publication Critical patent/JP2024123233A5/ja
Pending legal-status Critical Current

Links

JP2024103130A 2018-11-27 2024-06-26 肺腫瘍の検出におけるメチル化dna、rna、及びタンパク質の特性決定 Pending JP2024123233A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862771965P 2018-11-27 2018-11-27
US62/771,965 2018-11-27
PCT/US2019/063401 WO2020112869A1 (en) 2018-11-27 2019-11-26 Characterizing methylated dna, rna, and proteins in the detection of lung neoplasia
JP2021530259A JP7512278B2 (ja) 2018-11-27 2019-11-26 肺腫瘍の検出におけるメチル化dna、rna、及びタンパク質の特性決定

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021530259A Division JP7512278B2 (ja) 2018-11-27 2019-11-26 肺腫瘍の検出におけるメチル化dna、rna、及びタンパク質の特性決定

Publications (2)

Publication Number Publication Date
JP2024123233A JP2024123233A (ja) 2024-09-10
JP2024123233A5 true JP2024123233A5 (enExample) 2024-11-21

Family

ID=70853661

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021530259A Active JP7512278B2 (ja) 2018-11-27 2019-11-26 肺腫瘍の検出におけるメチル化dna、rna、及びタンパク質の特性決定
JP2024103130A Pending JP2024123233A (ja) 2018-11-27 2024-06-26 肺腫瘍の検出におけるメチル化dna、rna、及びタンパク質の特性決定

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021530259A Active JP7512278B2 (ja) 2018-11-27 2019-11-26 肺腫瘍の検出におけるメチル化dna、rna、及びタンパク質の特性決定

Country Status (10)

Country Link
US (1) US20220136058A1 (enExample)
EP (1) EP3886878A4 (enExample)
JP (2) JP7512278B2 (enExample)
KR (1) KR20210099044A (enExample)
CN (1) CN113423410A (enExample)
AU (1) AU2019389008A1 (enExample)
BR (1) BR112021009795A2 (enExample)
CA (1) CA3119329A1 (enExample)
MX (1) MX2021005963A (enExample)
WO (1) WO2020112869A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2816122A1 (en) 2008-02-15 2014-12-24 Mayo Foundation For Medical Education And Research Detecting neoplasm from a stool sample
US8361720B2 (en) 2010-11-15 2013-01-29 Exact Sciences Corporation Real time cleavage assay
US8916344B2 (en) 2010-11-15 2014-12-23 Exact Sciences Corporation Methylation assay
US11078539B2 (en) 2014-03-31 2021-08-03 Mayo Foundation For Medical Education And Research Detecting colorectal neoplasm
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
EP3274440B1 (en) 2015-03-27 2026-03-04 Exact Sciences Corporation Detecting esophageal disorders
KR102811214B1 (ko) 2015-10-30 2025-05-27 이그잭트 사이언시즈 코포레이션 복합 증폭 검출 분석 및 혈장으로부터 dna의 분리 및 검출 방법
CA3022911A1 (en) 2016-05-05 2017-11-09 Exact Sciences Development Company, Llc Detection of lung neoplasia by analysis of methylated dna
JP7289264B2 (ja) 2017-01-27 2023-06-09 エグザクト サイエンシーズ コーポレーション メチル化dnaの分析による結腸腫瘍の検出
KR20250117473A (ko) 2017-11-30 2025-08-04 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 유방암 검출방법
US10648025B2 (en) 2017-12-13 2020-05-12 Exact Sciences Development Company, Llc Multiplex amplification detection assay II
CA3149601A1 (en) * 2019-08-27 2021-03-04 Scott Morris Characterizing methylated dna, rna, and proteins in subjects suspected of having lung neoplasia
CN114651070A (zh) 2019-09-16 2022-06-21 精密科学公司 结构和温度依赖性瓣状核酸内切酶底物
WO2021087275A1 (en) 2019-10-31 2021-05-06 Mayo Foundation For Medical Education And Research Detecting ovarian cancer
US11898199B2 (en) 2019-11-11 2024-02-13 Universal Diagnostics, S.A. Detection of colorectal cancer and/or advanced adenomas
WO2021228418A1 (en) 2020-05-15 2021-11-18 Universal Diagnostics, S.L. Methods and systems for identifying methylation biomarkers
US11530453B2 (en) 2020-06-30 2022-12-20 Universal Diagnostics, S.L. Systems and methods for detection of multiple cancer types
EP3945135A1 (en) * 2020-07-27 2022-02-02 Les Laboratoires Servier Biomarkers for diagnosing and monitoring lung cancer
WO2022165247A1 (en) * 2021-01-29 2022-08-04 Mayo Foundation For Medical Education And Research Detecting the presence or absence of multiple types of cancer
CN115505640A (zh) * 2021-06-22 2022-12-23 上海鹍远生物科技股份有限公司 检测肺癌的dna甲基化标志物及应用
CN115725734B (zh) * 2022-08-10 2023-10-13 人和未来生物科技(长沙)有限公司 Znf781基因在制备宫颈癌诊断试剂中的应用
CN117683877A (zh) * 2023-12-19 2024-03-12 上海交通大学医学院 一种诊断或治疗免疫系统疾病的生物标志物或靶点

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070264659A1 (en) * 2006-05-11 2007-11-15 Sungwhan An Lung cancer biomarker discovery
WO2010064702A1 (ja) * 2008-12-05 2010-06-10 国立大学法人 東京大学 癌の予後を予測するためのバイオマーカー
US20110318738A1 (en) * 2008-12-23 2011-12-29 University Of Utah Research Foundation Identification and regulation of a novel dna demethylase system
US20130084287A1 (en) * 2011-09-30 2013-04-04 Genentech, Inc. Diagnostic markers
WO2013070950A1 (en) * 2011-11-08 2013-05-16 University Of Southern California Identification of a dna methylation marker for blood-based detection of ovarian cancer
US9546403B1 (en) * 2011-12-14 2017-01-17 University Of Utah Research Foundation Substrate for methylated DNA testing
EP3230744B1 (en) * 2014-12-12 2021-05-12 Exact Sciences Development Company, LLC Compositions and methods for performing methylation detection assays
JP6877704B2 (ja) * 2015-11-16 2021-05-26 公立大学法人名古屋市立大学 膵臓癌の検出のための方法及びキット
CA3022911A1 (en) * 2016-05-05 2017-11-09 Exact Sciences Development Company, Llc Detection of lung neoplasia by analysis of methylated dna
CA3026809A1 (en) * 2016-06-21 2017-12-28 The Wistar Institute Of Anatomy And Biology Compositions and methods for diagnosing lung cancers using gene expression profiles
EP3978624B1 (en) * 2016-07-19 2025-03-26 Exact Sciences Corporation Methylated control dna

Similar Documents

Publication Publication Date Title
JP2024123233A5 (enExample)
JP2025041764A5 (enExample)
JP2023025184A5 (ja) メチル化dnaの分析による腫瘍の検出
US11840739B2 (en) Gene composition for detecting cell proliferative abnormality or grading disease degree and use thereof
JP2020506680A5 (enExample)
US11396678B2 (en) Breast and ovarian cancer methylation markers and uses thereof
US9422592B2 (en) System and method of detecting RNAS altered by cancer in peripheral blood
US12359257B2 (en) Liver cancer methylation markers and uses thereof
JPWO2020112869A5 (enExample)
Marzese et al. Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer
US20090047656A1 (en) Molecular analysis of primary cells
US20130296328A1 (en) Epigenetic portraits of human breast cancers
EP3034624A1 (en) Method for the prognosis of hepatocellular carcinoma
Ortiz et al. Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma
CN110129436A (zh) Dna甲基化的数字序列分析
US7425415B2 (en) Method for detecting methylated CpG islands
US20140051082A1 (en) Prostate cancer markers
JPWO2021041726A5 (enExample)
CN107109468B (zh) 评估样品中甲基化基因座的量的方法
JP2024020392A (ja) 特定の遺伝子のcpgメチル化変化を利用した肝癌診断用組成物およびその使用
TW202417642A (zh) 鑑別癌症的甲基化標誌物及應用
CN110484621B (zh) 一种肝癌早期预警的方法
CN102016067A (zh) 前列腺癌中gstp1高甲基化的检测
US11535897B2 (en) Composite epigenetic biomarkers for accurate screening, diagnosis and prognosis of colorectal cancer
US20240344143A1 (en) Arrays targeting differentially accessible chromatin regions using quantitative polymerase chain reaction